Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Indivior's New Suboxone Patent Cannot Keep Dr. Reddy's Generic Off Market

Nov 27 2018

• By Brenda Sandburg

Federal Circuit closeup_683614828_1200.jpg

Related Content

Teva Sues US FDA To Obtain 180-Day Exclusivity For Its Generic Restasis

Oct 19 2018

US Suboxone Win Lifts Dr Reddy’s As Embattled Indivior Fights On

Nov 21 2018

Dr. Reddy's Launches First Generic Suboxone Film; Indivior May Seek Injunction

Jun 17 2018

Related Companies

Indivior plc

Dr. Reddy's Laboratories Ltd.

Viatris Inc.

Alvogen, Inc.

Par Pharmaceutical Companies Inc.

Teva Pharmaceutical Industries Ltd.

Allergan plc

Additional Topics

United States Intellectual Property Generic Drugs Legal Issues Policy BioPharmaceutical

More from Legal & IP

More from Generics Bulletin

About Us

About Us
Meet the TeamOpens in new window
RSS FeedOpens in new window
Download the App
Advertise with us

Account

Log in
SubscribeOpens in new window
My Account
My View
Email Alerts
Customer Service
AdvertisingOpens in new window
Feedback

Publications

Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window